Greenwich LifeSciences

$32.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.05 (-3.12%) Today
-$0.58 (-1.78%) As of 1:00 PM UTC after-hours

Why Robinhood?

You can buy or sell GLSI and other stocks, options, and ETFs commission-free!

About GLSI

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX. The listed name for GLSI is Greenwich LifeSciences, Inc. Common Stock.

CEO
Snehal Patel
Employees
—
Headquarters
Stafford, Texas
Founded
2006
Market Cap
385.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
221.36K
High Today
$35.81
Low Today
$32.14
Open Price
$34.50
Volume
193.21K
52 Week High
$158.07
52 Week Low
$3.26

GLSI Earnings

Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, Pre-Market

You May Also Like

IBDU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure